Claudia Nilges-Rueckes

Berlin, BE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Reduction of systemic inflammation by elexacaftor/tezacaftor/ivacaftor correlates with lung function improvement in cystic fibrosis.

Reduction of systemic inflammation by elexacaftor/tezacaftor/ivacaftor correlates with lung function improvement in cystic fibrosis.

Journal: The European respiratory journal

Published: January 23, 2025

Impact of elexacaftor/tezacaftor/ivacaftor therapy on lung clearance index and magnetic resonance imaging in children with cystic fibrosis and one or two F508del alleles.

Impact of elexacaftor/tezacaftor/ivacaftor therapy on lung clearance index and magnetic resonance imaging in children with cystic fibrosis and one or two F508del alleles.

Journal: The European respiratory journal

Published: January 01, 2024

Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on Lung Clearance Index and Magnetic Resonance Imaging in Patients with Cystic Fibrosis and One or Two F508del Alleles.

Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on Lung Clearance Index and Magnetic Resonance Imaging in Patients with Cystic Fibrosis and One or Two F508del Alleles.

Journal: American journal of respiratory and critical care medicine

Published: May 10, 2022

Personalized medicine with drugs targeting the underlying protein defect in cystic fibrosis: is monitoring of treatment response necessary?

Personalized medicine with drugs targeting the underlying protein defect in cystic fibrosis: is monitoring of treatment response necessary?

Journal: Therapeutic advances in chronic disease

Published: January 17, 2022

Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on CFTR Function in Patients with Cystic Fibrosis and One or Two F508del Alleles.

Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on CFTR Function in Patients with Cystic Fibrosis and One or Two F508del Alleles.

Journal: American journal of respiratory and critical care medicine

Published: December 22, 2021

Multicentre feasibility of multiple-breath washout in preschool children with cystic fibrosis and other lung diseases.

Multicentre feasibility of multiple-breath washout in preschool children with cystic fibrosis and other lung diseases.

Journal: ERJ open research

Published: June 20, 2020

Effects of Lumacaftor-Ivacaftor Therapy on Cystic Fibrosis Transmembrane Conductance Regulator Function in Phe508del Homozygous Patients with Cystic Fibrosis.

Effects of Lumacaftor-Ivacaftor Therapy on Cystic Fibrosis Transmembrane Conductance Regulator Function in Phe508del Homozygous Patients with Cystic Fibrosis.

Journal: American journal of respiratory and critical care medicine

Published: January 13, 2018

Intestinal current measurement versus nasal potential difference measurements for diagnosis of cystic fibrosis: a case-control study.

Intestinal current measurement versus nasal potential difference measurements for diagnosis of cystic fibrosis: a case-control study.

Journal: BMC pulmonary medicine

Published: June 18, 2014

Nasal potential difference: Best or average result for CFTR function as diagnostic criteria for cystic fibrosis?

Nasal potential difference: Best or average result for CFTR function as diagnostic criteria for cystic fibrosis?

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: May 26, 2014

Showing 1-9 of 9

Last Updated: 09/26/2026